Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial

Although methylphenidate hydrochloride (MPH) is a first-line treatment for children with attention-deficit hyperactivity disorder (ADHD), the non-response rate is 30%. Our aim was to develop a supplementary neuroimaging biomarker for predicting the clinical effect of continuous MPH administration by...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuropsychopharmacology
Hlavní autoři: Ishii-Takahashi, Ayaka, Takizawa, Ryu, Nishimura, Yukika, Kawakubo, Yuki, Hamada, Kasumi, Okuhata, Shiho, Kawasaki, Shingo, Kuwabara, Hitoshi, Shimada, Takafumi, Todokoro, Ayako, Igarashi, Takashi, Watanabe, Kei-ichiro, Yamasue, Hidenori, Kato, Nobumasa, Kasai, Kiyoto, Kano, Yukiko
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864654/
https://ncbi.nlm.nih.gov/pubmed/25936640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2015.128
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky